GENOMICS AND PROTEOMICS REAGENTS, RESEARCH KITS, & ANALYTICAL INSTRUMENTATION MARKET ANALYSIS (2020-2027)

1

• Coherent Market Insights
• Market Research and Business Consulting Services
• https//www.coherentmarketinsights.com/
• COVID-19 Impact Tracker

2
GENOMICS AND PROTEOMICS REAGENTS, RESEARCH KITS,
ANALYTICAL INSTRUMENTATION MARKET ANALYSIS
(2020-2027)

• Genomics and Proteomics Reagents, Research Kits,
  Analytical Instrumentation Market, By Product
  Type (Instrumentation and Analytical Tools
  (Chromatography, Mass Spectrometry, Thermal
  Cyclers, Next Gen Sequencing), Reagents and
  Research Kits (Sample Prep Kits, Electrophoresis
  Kits, Purification Kits, BioChips)), By End User
  (Diagnostic Laboratories, Pharmaceutical and
  Biotechnology Organizations, Research
  Laboratories), and By Region (North America,
  Latin America, Europe, Asia Pacific, Middle East
  Africa) - Size, Share, Outlook, and Opportunity
  Analysis, 2020 - 2027

3

• Genomics and proteomics form the core omics
  fields of life science research and account for a
  majority share of research in healthcare
  industry. The fields find application in
  agriculture and animal husbandry, drug discovery,
  forensics, proteogenomics research, and disease
  identification, diagnostics, and control.
• The global genomics and proteomics reagents,
  research kits, and analytical instrumentation
  market is estimated to account for US 59,185.3
  Mn in terms of value in 2020 and is expected to
  reach US 132,162.2 Mn by the end of 2027.

4

• Global Genomics and Proteomics Reagents, Research
  Kits, and Analytical Instrumentation Market
  Drivers
• Increasing investment in the pharmaceutical
  sector is expected to propel growth of the global
  genomics and proteomics reagents, research kits,
  and analytical instrumentation market over the
  forecast period. For instance, according to The
  European Federation of Pharmaceutical Industries
  and Associations Key Data 2019, the
  pharmaceutical sector in Europe invested US 19,
  509 million in 2000, which increased to US
  39,895 million (est.) in 2018.
• Moreover, increasing approval and launch of drugs
  is also expected to aid in growth of the market.
  For instance, in 2019            the U.S. Food
  and Drug Administrations Center for Drug
  Evaluation and Research (CDER) approved 48 novel
  drugs and European Medicines Agency reported that
  30 new active substances were approved in the
  same year.  

5

• Global Genomics and Proteomics Reagents, Research
  Kits, and Analytical Instrumentation Market
  Drivers
• Thermal cyclers held dominant position in the
  global genomics and proteomics reagents, research
  kits, and analytical instrumentation market in
  2019, accounting for 34.8 share in terms of
  value, followed by Europe and Asia Pacific,
  respectively.

6
Figure 1 Global Genomics and Proteomics
Reagents, Research Kits, and Analytical
Instrumentation Market Share () Value, By
Region, 2019
7

• Global Genomics and Proteomics Reagents, Research
  Kits, and Analytical Instrumentation Market
  Restraints
• Low adoption and penetration of reagents,
  research kits, and analytical instrumentation in
  developing countries is expected to hinder growth
  of the market. This can be attributed to the high
  cost of the equipment and high capital investment
  required to set up a modern laboratory.
• Moreover, the market is highly fragmented, which
  increases volume but reduced revenue of the
  market. This in turn is expected to hinder growth
  of the market.

8
(No Transcript)
9

• Global Genomics and Proteomics Reagents, Research
  Kits, and Analytical Instrumentation Market
  Opportunities
• Increasing prevalence of chronic disorders is
  expected to offer lucrative growth opportunities
  for players in the global genomics and proteomics
  reagents, research kits, and analytical
  instrumentation market. For instance, according
  to the American Cancer Society, in 2019, there
  will be an estimated 1,762,450 new cancer cases
  diagnosed and 606,880 cancer deaths in the U.S.  
• Moreover, increasing adoption of proteomics in
  disease diagnostics is also expected to aid in
  growth of the market. For instance, in September
  2019, researchers from Eulji University, South
  Korea, reported use of proteomics approach to
  identify two proteins, namely serum amyloid A4
  and vitamin D binding protein that demonstrated
  high performance in distinguishing patients with
  rheumatoid arthritis from healthy controls.

10
Figure 2 Global Genomics and Proteomics
Reagents, Research Kits, and Analytical
Instrumentation Market Value (US Mn), 2016 2027
11

• Market Trends/Key Takeaways
• Major players in the market are focused on
  adopting partnership strategies to expand their
  product portfolio. For instance, in October 2019,
  Illumina, Inc. partnered with QIAGEN N.V. to
  broaden the availability and use of NGS-based
  in-vitro diagnostic kits, including companion
  diagnostics, for patient management.
• Major players in the market are also focused on
  adopting MA strategies to expand their product
  portfolio. For instance, in November 2018, 
  Agilent Technologies Inc. acquired ACEA
  Biosciences Inc., a developer of cell analysis
  tools, for US 250 million in cash.

12

• Global Genomics and Proteomics Reagents, Research
  Kits, and Analytical Instrumentation Market
  Competitive Landscape
• Major players operating in the global genomics
  and proteomics reagents, research kits, and
  analytical instrumentation market include, Thermo
  Fisher Scientific, Agilent Technologies, Becton
  Dickinson Company, Bio-Rad Laboratories, Inc.,
  Bruker Corporation, Danaher Corporation,
  Illumina, Inc., Life Technologies Corporation,
  and Merck Millipore.

13

• Global Genomics and Proteomics Reagents, Research
  Kits, and Analytical Instrumentation Market Key
  Developments
• Major players in the market are focused on
  adopting partnership strategies to expand their
  product portfolio. For instance, in January 2020,
  Agilent Technologies Inc. collaborated with
  Indian Institute of Technology Delhi, India, to
  promote biopharmaceutical research.
• Similarly, in September 2019, Bruker Corporation
  collaborated with Murdoch University for RD in
  prevention and diagnosis of diseases through the
  Australian National Phenome Center, the
  international center of expertise for metabolic
  phenotyping.

14

• Request Sample Report
• Request Customization
• Download PDF Brochure
• Talk to Analyst
• Buy Now
• Reference https//www.coherentmarketinsights.com/
  market-insight/genomics-and-proteomics-reagents-re
  search-kits-and-analytical-instrumentation-market-
  4109

15
About Us

• Coherent Market Insights is a global market
  intelligence and consulting organization focused
  on assisting our plethora of clients achieve
  transformational growth by helping them make
  critical business decisions.
• What we provide
• Customized Market Research Services
• Industry Analysis Services
• Business Consulting Services
• Market Intelligence Services
• Long term Engagement Model
• Country Specific Analysis

16
Contact Us

• Mr. Shah
• Coherent Market Insights Pvt.Ltd.
• Address 1001 4th Ave, 3200 Seattle, WA 98154,
  U.S.
• Phone [phone]
• Email sales_at_coherentmarketinsights.com

17

• Thank You!
• Kindly follow CMI Social Media
  Profiles for the latest company updates
• Facebook
• Linkedin
• Twitter
• https//www.coherentmarketinsights.com/